Literature DB >> 7488272

Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology.

M C Hochberg1, R D Altman, K D Brandt, B M Clark, P A Dieppe, M R Griffin, R W Moskowitz, T J Schnitzer.   

Abstract

Treatment of patients with OA of the hip should be individualized and tailored to the severity of the disease. In individuals with mildly symptomatic disease, treatment may be limited to patient education, physical and occupational therapy, other nonpharmacologic modalities, and drug therapy with a non-opioid oral analgesic. In patients who are unresponsive to this treatment regimen, the use of an NSAID in addition to nonpharmacologic therapy is appropriate unless it is medically contraindicated. Patients with severe symptomatic OA of the hip require an aggressive approach to decreasing pain, increasing mobility, and improving function; such patients may benefit from orthopedic consultation and evaluation for osteotomy or total joint arthroplasty.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488272     DOI: 10.1002/art.1780381103

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  77 in total

1.  Are topically applied nonsteroidal anti-inflammatory drugs effective and safe?

Authors:  R Glazier; L Steele
Journal:  Can Fam Physician       Date:  1999-07       Impact factor: 3.275

Review 2.  Rheumatology: 7. Basics of therapy.

Authors:  S H Huang
Journal:  CMAJ       Date:  2000-08-22       Impact factor: 8.262

Review 3.  Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint.

Authors:  J A Chard; D Tallon; P A Dieppe
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

4.  Key questions concerning paracetamol and NSAIDs for osteoarthritis.

Authors:  P Courtney; M Doherty
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

5.  Global treatment of osteoarthritis.

Authors:  George E Ehrlich
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

6.  Inpatient rehabilitation for hip or knee osteoarthritis: 2 year follow up study.

Authors:  M Weigl; F Angst; G Stucki; S Lehmann; A Aeschlimann
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

Review 7.  EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; N Arden; B Bannwarth; J Bijlsma; K-P Gunther; H J Hauselmann; G Herrero-Beaumont; K Jordan; P Kaklamanis; B Leeb; M Lequesne; S Lohmander; B Mazieres; E Martin-Mola; K Pavelka; A Pendleton; L Punzi; B Swoboda; R Varatojo; G Verbruggen; I Zimmermann-Gorska; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-10-07       Impact factor: 19.103

8.  Sex differences in hip osteoarthritis: results of a longitudinal study in 508 patients.

Authors:  J F Maillefert; A Gueguen; M Monreal; M Nguyen; L Berdah; M Lequesne; B Mazieres; E Vignon; M Dougados
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

9.  Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.

Authors:  T Pincus; G Koch; H Lei; B Mangal; T Sokka; R Moskowitz; F Wolfe; A Gibofsky; L Simon; S Zlotnick; J G Fort
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

10.  Acetylsalicylic acid combined with diclofenac inhibits cartilage degradation in rabbit models of osteoarthritis.

Authors:  Jianqiang Liu; Changshun Wu; Dong Wang; Laicheng Wang; Shui Sun
Journal:  Exp Ther Med       Date:  2016-08-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.